ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Medicine / Sub specialtie
Public health
Medicine / Pharmacology
Biology
Research
Chemistry
Medicine / Gynecology
Architecture and Urbanism
Pure sciences
Technology
all records (21)

Languages
English
Spanish
Portuguese

Countries
Indonesia
USA
Brazil
India
Colombia
Malaysia
Bangladesh
Italy
Mexico
Canada
all records (14)

Years
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
all records (16)

Filter  
 
67  Articles
1 of 8 pages  |  10  records  |  more records»
Tamoxifen citrate (TC) is one of the anti-estrogen agents which has low solubility in the water. As TC is still used as the main therapy in breast cancer treatment, modifications are still being made to increase the solubility of TC for a successful treat... see more

Breast cancer and cervical cancer are among the leading causes of death among women in the world. The development of drug resistance in both cancer cells, has reduced the efficacy of chemotherapeutic drugs in cancer treatment. The current study was aimed ... see more

Breast cancer is the most frequently occurring malignant neoplasm among women. Statistically, it constitutes 22,8% of all malignant neoplasms among females. Despite the fact that the causes of the disease remain unknown, a few risk factors are contributin... see more

Several previous studies show that adherence to hormonal therapy increases the survival rate in Breast Cancer (BC) with ER+ or PR+. Tamoxifen is one of oral chemotherapy which is the most used hormonal therapy in breast cancer treatment regimens. The focu... see more

Introduction: Tamoxifen citrate is an anti-estrogen agent used in the treatment of breast carcinoma. Crystalline maculopathy is a rare complication of tamoxifen therapy. The clinical picture resembles that of idiopathic macular telangiectasia (IMT) Type 2... see more

Literatures about case-control study on the association between CYP2D6*10 gene polymorphism and breast cancer were searched from last updated on May, 2014. Odds ratio of CYP2D6*10 gene distributions in breast cancer patients against healthy control were a... see more

17ß-Estradiol (E2) plays a pivotal role in the development and progression of breast cancer. As a result, blockade of the E2 signal through either tamoxifen (TAM) or aromatase inhibitors is an important therapeutic strategy to treat or prevent estrogen re... see more

Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar histopathological abnormalities have been revealed after ovulation stimulation. Given that tamoxifen (TAM) ha... see more

AbstractObjective: Selective estrogen receptor modulators (SERMs) such as tamoxifen play a role in increasing the risk of developing uterine Fibroid.Methods:  Case reportCase: Mrs. 47 years old, Para 6, presented with chief complaints of vaginal blee... see more

1 of 8 pages  |  10  records  |  more records»